Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies
Gastrointestinal malignancies are common digestive system tumor worldwide. Nucleoside analogues have been widely used as anticancer drugs for the treatment of a variety of conditions, including gastrointestinal malignancies. However, low permeability, enzymatic deamination, inefficiently phosphoryla...
Main Authors: | Xingxing Xu, Zixuan Li, Xueying Yao, Nannan Sun, Junbiao Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2023.1173432/full |
Similar Items
-
Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years
by: Hanadi Sinokrot, et al.
Published: (2017-10-01) -
Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells
by: Jean A. Bernatchez, et al.
Published: (2019-04-01) -
Current prodrug strategies for improving oral absorption of nucleoside analogues
by: Youxi Zhang, et al.
Published: (2014-04-01) -
Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects
by: Marcela Krečmerová, et al.
Published: (2022-05-01) -
Lipophilic Nucleoside Triphosphate Prodrugs of Anti‐HIV Active Nucleoside Analogs as Potential Antiviral Compounds
by: Xiao Jia, et al.
Published: (2023-12-01)